Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson's Disease

Min Zhong1, Ruxin Gu1, Sha Zhu1

  • 1Department of Geriatric Neurology, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.

Behavioural Neurology
|October 14, 2021
PubMed
Abstract

Insights

Minor hallucinations (MHs) are common in Parkinson's disease (PD), affecting nearly 40% of patients. These early symptoms are linked to worse quality of life, sleep issues, and rapid eye movement sleep behavior disorder (RBD).

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Minor hallucinations (MHs) are the earliest and most frequent psychotic symptom in Parkinson's disease (PD).
  • MHs can precede motor symptom onset and may predict severe cognitive and psychotic states.
  • These symptoms are often underdiagnosed in clinical settings.

Purpose of the Study:

  • To comprehensively understand the prevalence and clinical characteristics of MHs in Parkinson's disease.
  • To identify factors associated with the occurrence of MHs in PD patients.

Main Methods:

  • Demographic and clinical data were collected from 262 PD patients.
  • Patients were categorized into MH and non-hallucination (NH) groups based on the Movement Disorders Society Unified Parkinson's Disease Rating Scale Part I.
  • Clinical assessments included questionnaires on quality of life and nonmotor symptoms.

Main Results:

  • MHs were prevalent in 38.9% of PD patients, with visual illusions (object misidentification) being the most common.
  • Patients with MHs had longer disease duration, higher levodopa equivalent doses, and greater use of dopamine agonists.
  • The MH group exhibited poorer quality of life, worse sleep quality, and a higher prevalence of rapid eye movement sleep behavior disorder (RBD).

Conclusions:

  • Minor hallucinations are highly prevalent in Parkinson's disease.
  • Rapid eye movement sleep behavior disorder, poor sleep quality, and reduced health-related quality of life are significantly associated with MHs.
  • Further research is warranted to validate these findings and explore their prognostic and therapeutic implications.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
444
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
840
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
159
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
324
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.2K
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
239